Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study

BACKGROUND: Cardiovascular disease (CVD) is the most frequent cause of death in Austria. The European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines recommend intensive lipid lowering therapy (LLT) in patients at high or very high CV risk. Lipid management and achievem...

Descripción completa

Detalles Bibliográficos
Autores principales: Siostrzonek, Peter, Brath, Helmut, Zweiker, Robert, Drexel, Heinz, Hoelzl, Robert, Hemetsberger, Margit, Ray, Kausik K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023395/
https://www.ncbi.nlm.nih.gov/pubmed/34870742
http://dx.doi.org/10.1007/s00508-021-01978-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023395/
https://www.ncbi.nlm.nih.gov/pubmed/34870742
http://dx.doi.org/10.1007/s00508-021-01978-w

Ejemplares similares